Skip to content
Catalyst

Ginkgo bilobaFinding

Ginkgo biloba decreases haematocrit

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“Five articles reported hematocrit (Hct), and meta-analysis results showed that GKB also had lower Hct than control (SMD=-0.60, 95%CI [-0.97, -0.24], P<0.01).”
Quoted verbatim from Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis.
This finding among the 7 findings on its endpoint

Ginkgo biloba

Haematocrit

lowers

Effect as reported

−0.6standardised mean difference

CI −0.97 to −0.24

Who
Patients with type 2 diabetes mellitus; five pooled randomised trials, most adding the extract to metformin against metformin alone
Dose studied
not reported

Moderate evidencePMID 38264278 · 2023

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Frontiers in endocrinology
What else it reported6 findings · 0 compounds · 6 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZB24RRT0JB8R88R572DFC4